[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes
Open Access
- 1 May 2011
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 6 (1), 44
- https://doi.org/10.1186/1748-717X-6-44
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical evidence on PET/CT for radiation therapy planning in prostate cancerRadiotherapy and Oncology, 2010
- [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomyWorld Journal of Urology, 2009
- Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794Journal of Clinical Oncology, 2007
- 18F‐choline and/or 11C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen values (<1 ng/mL) after radical prostatectomyBJU International, 2007
- [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)The Lancet, 2005
- Positron Emission Tomography for Radiation Treatment PlanningStrahlentherapie Und Onkologie, 2005
C -Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate CancerEuropean Urology, 2003- Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.2003
- PET imaging of prostate cancer using carbon-11-choline.1998